Botulinum Toxin A Linurase® by Prollenium

Prollenium Medical Technologies was opened in 2002 with a team of researchers and directors with over 25 years of experience in the medical aesthetic industry.

Prollenium Medical Technologies is in the process of commencing additional clinical studies on its proprietary Botulinum Toxin Type A.
That's all I have for now. So another possible competitor that may take on Allergan's "super-power" Botox, Ipsen's Dysport and Merz's newly FDA-approved Xeomin.